I have been a scientist for the past 25 years during which time I have assumed a number of different roles at various institutions and companies. My primary focus and goal has, and will continue to remain, on identifying ways in which I can benefit humankind, be it in the realm of cancer (targeted therapeutics, evidence-based information services for physician-driven treatment options) or renal cystogenesis (the study of signaling pathways that contribute to disease development and identifying potential therapeutic options). I strongly believe in collaborative science, and the bringing together of multiple different disciplines to investigate a problem from a variety of perspectives.

My primary research interests lie in studying signal transduction pathways and how they contribute to the development and progression of disease in epithelial systems. Most recently this has been in the context of Polycystic Kidney Disease (PKD), which currently has only one FDA-approved therapy. My latest research has uncovered a potential novel role of defective nutrient sensing as a contributor to PKD.